NCT01279252View on ClinicalTrials.gov

CLL Empirical Antibiotic Regimen

PHASE2CompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

January 31, 2015

Study Completion Date

March 31, 2016

Conditions
Chronic Lymphocytic Leukaemia (CLL)
Interventions
DRUG

metronidazole, clarithromycin, ciprofloxacin and lansoprazole

Trial Locations (1)

SE5 9RS

King's College Hospital NHS Foundation Trust, London

All Listed Sponsors
lead

King's College Hospital NHS Trust

OTHER

NCT01279252 - CLL Empirical Antibiotic Regimen | Biotech Hunter | Biotech Hunter